Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Journal of Human Hypertension (1999) 13, 367–374 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet on blood pressure S Alam and AG Johnson The University of Queensland Department of Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia To examine the effect of chronic NaCl ingestion on blood pressure (BP) in the elderly, a meta-analysis was undertaken of 11 randomised controlled trials of which five included patients ⭓60 years of age only and six included patients with a mean age close to 60 years. The following databases were used: Medline, Embase, Current Contents, The Cochrane Library, the AMI and IPA databases. Mean erect systolic and diastolic blood pressures (SBP/DBP) on chronic (⭓9 weeks) high and low NaCl diets were recorded, the pooled mean effect, the pooled standard error and 95% confidence intervals (CI) were calculated and linear regression was used to evaluate the potential association between NaCl intake and BP. When all trials were pooled, a chronic high NaCl diet significantly increased mean SBP and DBP by 5.58 mm Hg (95%CI 4.31–6.85) and 3.5 mm Hg (95%CI 2.62– 4.38) respectively. There was a significant association between the level of NaCl intake and SBP (P ⴝ 0.05, r2 ⴝ 0.37) but not DBP (P ⴝ 0.76, r2 ⴝ 0.01). When trials were pooled separately, a chronic high NaCl diet increased SBP by 5.46 mm Hg (95%CI 3.56–7.36) and DBP by 2.63 mm Hg (95%CI 1.18– 4.08) in trials including patients ⭓60 years of age only, and increased SBP by 3.27 mm Hg (95%CI 1.23–5.31) and DBP by 2.69 mm Hg (95%CI 1.44 –3.94) in trials including patients with a mean age close to 60 years. These data suggest that a chronic high NaCl diet in elderly patients with essential hypertension is associated with an increase in SBP and DBP, the association is significant for both SBP and DBP but more marked for SBP than DBP, the effect is more pronounced the older the patient and NaCl dose strongly predicts SBP in older patients. Keywords: meta-analysis; randomised trials; elderly; essential hypertensive; high NaCl; blood pressure Introduction Isolated systolic hypertension (ISH) defined as systolic blood pressure (SBP) ⭓160 mm Hg and diastolic blood pressure (DBP) ⬍90 mm Hg is prevalent in the elderly with a substantial morbidity and mortality.1 In the Intersalt study, an age associated increase in SBP was positively related to the mean Na excretion of individuals in each country raising the importance of chronic high Na intake for the initiation and/or maintenance of hypertension.2 In addition, the elderly have been reported to have a higher prevalence of sensitivity of their BP responses to ingested NaCl than younger individuals.3–5 Na retention and hypertension in the elderly is possibly due to a complex interaction between neuroendocrine factors and the kidney.6 Although several meta-analysis have been reported in younger Correspondence: Shahin Alam, Department of Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, QLD 4102, Australia Received 13 November 1998; revised 1 February 1999; accepted 2 February 1999 adults to show a modest hypertensive effect of chronic high NaCl intake,7 there have been none published which were focused on elderly individuals. We therefore undertook a meta-analysis of elderly subjects to evaluate the effect of chronic high NaCl diet on their BP and to examine for differential effects on SBP and DBP. Materials and methods Computerised English-language literature searches were undertaken of published randomised human trials evaluating the effect of changes in dietary NaCl on BP in healthy, essential hypertensive individuals. These searches included Medline Express (January 1966 to May 1998), Embase (1988–1998), Current Contents (October 97–December 97 and January 98–April 98), AMI (1966–May 1998), API (1970–May 98) and the Cochrane Library. Search strategies included the following terms: ‘hypertens*’, ‘hypertension’, ‘blood pressure’, ‘isolated systolic hypertension’, ‘salt’, ‘dietary salt’, ‘sodium diet’, ‘sodium chloride diet’, ‘salt diet’, ‘dietary sodium’, ‘Na diet’, ‘NaCl’, ‘elderly’, ‘age’, ‘aging’, ‘geriatr*’, Meta-analysis of NaCl and BP in the elderly S Alam and AG Johnson 368 ‘aged’, ‘meta-analysis’ and ‘randomised’, ‘random allocation’, ‘random’, ‘control’, ‘clinical trials’, ‘meta-analysis’, ‘double-blind method’, ‘doubleblind study’, ‘double’ and ‘blind’. Bibiliographies of review and primary articles were also explored. The search yielded 251 papers. The methods and results sections of all 251 selected manuscripts were reviewed independently by two authors (SA & AJ). Inclusion criteria were: randomised controlled trials (RCT) of the effect of chronic NaCl ingestion on BP in the elderly where BP and age data were provided. The final decision to include or reject a study was reached by consensus between two of the authors (SA & AJ). It was our intention to score the quality of each study as we planned to include only high quality studies for this meta-analysis. However, we found that by restricting studies for inclusion to those with a randomised design the quality assessment score8 tended to be high for each trial. Consequently, no randomised trials were excluded based on quality assessment score (average score ⬎70%). However, only six trials involved elderly subjects (⭓60 years). Although the two9,10 papers refer to different aspects they came from the same study and represent similar data. However, for the meta-analysis one set of data can be used only. One9 of these two trials was included in this meta-analysis together with a further six trials involving subjects with a mean age close to 60 years (ie, 59.5, 58.4, 58.6, 58.4 age range (50–64) and age ⬎50 years). The remaining 239 trials were excluded due to the following reasons: five trials were randomised but did not provide age data; 14 trials were randomised but failed to provide BP data adequate for the metaanalysis; one trial measured BP changes with consumption of dietary NaCl but randomised the study subjects into two groups on the basis of potassium: magnesium salt with both patients and controls receiving NaCl; one trial included patients ⬎60 years but did not provide BP data on dietary changes of Na because the study intention was to measure heart rate variability with alteration in Na diet; and 218 trials were randomised but studied younger individuals. Consequently, relevant identifying data were recorded (Table 1) for 11 trials9,11–20 which were included in the meta-analysis. Relevant data were extracted by two authors (SA & AJ) independently, including year of publication, population characteristics, diagnosis, intervention, study duration and measurements (BP, heart rate, weight, urinary Na). Discrepancies in data extraction were noted by both authors and a subset was compared for differences in data extracted–no differences were identified (r = 1). Where BP data were provided (only in graphic form) it was estimated from the published figures available. Where a quantification of NaCl intake was not published, 24h urinary Na was used as a surrogate. The RCTs evaluating the effect of high NaCl vs low NaCl on healthy essential hypertensive elderly patients were pooled into two broad categories— those trials where all participants were aged above 60 years (five trials) (Tables 3A, 3B) and those where the mean age was close to 60 years (four trials) (Tables 4A, 4B)—two trials were excluded. One19 because of a substantially greater difference in Na dose and the second20 due to a substantially smaller difference in NaCl dose from the remaining studies. However, all trials included for analysis were randomised, evaluated BP effects of high vs low chronic NaCl dose and studied healthy older patients with essential hypertension. Therefore, it was considered appropriate to pool data from all 11 studies. The mean difference, standard errors and standard deviation of SBP and DBP between high and low NaCl diet for each trial was calculated.21,22 Ninetyfive percent confidence intervals (95%CI) for each trial were also calculated for mean erect SBP and DBP (Table 2A and B, respectively).23 Standard error of the difference between means (s.e.) was calculated for each trial.22 There was insufficient data for other parameters including heart rate and 24-h urinary Na to be included in the meta-analysis. The pooled estimate of the standard deviation (s.d.) and variance of the difference (Vd) between the effect of high NaCl and low NaCl diets for each trial was calculated.21 The pooled mean effect of high NaCl compared with low NaCl diets on 24-h average SBP and DBP was determined by using the standardised mean effect weighted by the inverse of the variance of the difference for each trial.24,25 The pooled standard error and the corresponding 95%CIs were then calculated.24 Linear regression modelling was used to evaluate the potential association between high dietary NaCl intake and BP. The standardised weighted mean was calculated by dividing the pooled mean treatment effect by the associated standard error.26 Results Table 1 shows a summary of the 11 trials which met the study criteria and were included in the metaanalysis. Eight trials were crossover design with three using a parallel design. Nine involved essential hypertensive patients and the remaining two12,13 used normotensive subjects. Because the mean BP changes in normotensive and hypertensive subjects were comparable, they were pooled. Of the total 485 subjects, 92.8% completed these trials. The average trial sample size was 44 and the average trial quality assessment score was 73. The 95%CI for each trial was estimated for mean erect SBP and DBP (Table 2A, B, respectively). Nine of 11 trials provided stratification by sex and overall male:female ratio was 2.11:1. Eleven trials with 90.9% performed in English speaking countries were pooled into three different ways (Tables 3 to 5). SBP and DBP data averages for each trial was pooled separately. For 36% of the trials, the diet was either not specified or stated to be normal. Trial duration was ⭓9 weeks for all studies included. The average trial duration was 25.4 weeks and the treatment period was from 9 to 104 weeks. Tables 3A and 3B included subjects aged ⭓60 years and weighted pooled mean increases in erect SBP and DBP were 5.46 mm Hg (pooled estimates of 95%CIs were 3.56–7.36) and 2.63 mm Hg (CIs 1.18– 4.08) respectively, due to increased NaCl consumption (low to high NaCl diet). The standardised Table 1 Study details of randomised, controlled trials (1978–1997) Age (years) Sex Study design Low Salt diet (mmol/d) High Salt diet (mmol/d) Sample size Drop-out Study duration (weeks) Quality assessment score Ethic’s approval Site Nestel et al, 199311 Palmer et al, 198912 Fotherby et al, 19979 Schorr et al, 199613 Cappuccio et al, 199714 Weir et al, 199515 Lancet, 198916 60–79 36 M 30 F 1M 6W 4M 13 W 10 M 11 W 24 M 23 W 14 M 8F 93 M 18 F 7M Crossover 80 160 70 4 10 77 Yes Australia Crossover 43 175 7 1 16 67 Yes USA Crossover 80 160 17 0 14 80 Unknown UK Crossover ⭐100 ⭐360 21 5 18 83 Yes Germany Crossover 80 200 52 5 10 86 Yes UK Crossover 40 200 22 0 9 83 Yes USA Parallel 80 160 111 8 14 67 Yes Australia Crossover 10 250 7 2 10 59 Unknown USA Crossover 80 160 88 0 22 70 Yes Australia Parallel 100 138 28 3 52 71 Unknown UK 62 0 104 58 Unknown Australia Kurtz et al, 198719 Clin Ex Hyp, 198917 Silman et al, 198318 Morgan et al, 197820 78–96 66–79 60–72 60–78 59.5 ± 3* 58.4 ± 1* 58.4 58.6 ± 1.1* 50–64 ⬎50 73 M 15 F 28 (not reported) 62 (not reported) Parallel 157 (urinary Na) 180 (urinary Na) Meta-analysis of NaCl and BP in the elderly S Alam and AG Johnson Study reference * Mean ± s.e.m. (standard error of the mean). 369 Meta-analysis of NaCl and BP in the elderly S Alam and AG Johnson 370 Table 2 Meta-analysis of randomised, placebo-controlled trials (1978–1997) Trials Nestel et al, 1993 Palmer et al, 1989 Fotherby et al, 1997 Schorr et al, 1996 Cappuccio et al, 1997 Weir et al, 1995 Lancet, 1989 Kurtz et al, 1987 Clin Exp Hyp, 1989 Silman et al, 1983 Morgan et al, 1978 Reference 11 12 9 13 14 15 16 19 17 18 20 Weighted pooled mean change* 95% confidence intervals Weighted pooled mean change† A Systolic blood pressure 4.82 1.55–8.09 10.29 1.74 –18.84 6 (−0.62)–12.62 7.15 1.05–13.25 3.9 (−1)–8.8 5 (−1.35)–11.35 3.1 (−0.72)–6.92 16 10.45–21.55 3.6 (−0.56)–7.76 0.5 (−7.0)–8.0 7.6 2.6–12.6 95% Confidence intervals B Diastolic blood pressure 2.28 (−0.5)–5.06 5.43 (−0.98)–11.84 3 (−1.82)–7.82 2.86 (−1.61)–7.33 2.1 (−1.17)–5.37 1 (−3.39)–5.39 3.2 0.73–5.67 8 3.2–12.8 2.1 (−0.13)– 4.33 5.6 0.68–10.52 9.3 5.91–12.69 Weighted pooled mean change of *SBP and †DBP with high salt diet. Table 3A Pooled mean SBP with low and high salt diet Study details Nestel et al, 1993 Palmer et al, 1989 Fotherby et al, 1997 Schorr et al, 1996 Cappuccio et al, 1997 Age (years) 60–79 78–96 66–79 60–72 60–78 Low Na SBP (erect) (mm Hg) 122.91 ± 9.55* 144.14 ± 8.77# 168 ± 25* 125.71 ± 15.71* 151.1 ± 21.2* High Na DBP (erect) (mm Hg) 127.73 ± 13.18* 154.43 ± 10.22# 174 ± 22* 132.86 ± 22.86* 155 ± 21.5* Weighted pooled mean change (mm Hg) s.d. difference Variance difference (Vd) 4.82 10.29 6 7.15 3.9 11.51 23.32 23.55 19.61 21.35 2 13.46 8.08 6.93 4.4 * Mean ± s.d. (standard deviation). # Mean ± s.e.m. (standard error of the mean). Pooled mean treatment effect: 5.46 mm Hg. Associated standard error: 0.97. Pooled estimates of 95% confidence intervals: 3.56–7.36. Table 3B Pooled mean DBP with low and high salt diet Study details Nestel et al, 1993 Palmer et al, 1989 Fotherby et al, 1997 Schorr et al, 1996 Cappuccio et al, 1997 Age (years) Low Na DBP (erect) (mm Hg) High Na DBP (erect) (mm Hg) Weighted pooled mean change (mm Hg) s.d. difference Variance difference (Vd) 60–79 78–96 66–79 60–72 60–78 72.45 ± 7.36* 70.86 ± 4.85# 99 ± 12* 70 ± 9.29* 91.6 ± 8.7* 74.73 ± 9* 76.29 ± 5.83# 102 ± 13* 72.86 ± 11.43* 93.7 ± 10.5* 2.28 5.43 3 2.86 2.1 8.22 13.13 12.51 10.42 9.64 1.43 7.58 4.29 3.86 1.99 * Mean ± s.d. (standard deviation). # Mean ± s.e.m. (standard error of the mean). Pooled mean treatment effect: 2.63 mm Hg. Associated standard error: 0.74. Pooled estimates of 95% confidence intervals: 1.18– 4.08. weighted mean26 increase in SBP was 1.59 times more when compared with DBP, which suggests that the effect of salt on SBP is greater than on DBP. Tables 4A and 4B included four and excluded two trials because of data inconsistency. From the remaining four trials, subjects with a mean age below but close to 60 years and weighted pooled mean increase in erect SBP and DBP of 3.27 mm Hg (pooled estimates of 95%CIs were 1.23–5.31) and 2.69 mm Hg (CIs 1.44 –3.94) respectively due to increased NaCl consumption (low to high NaCl diet). The standardised weighted mean26 increase in SBP was 0.75 times more when compared with DBP. Tables 5A and 5B included 11 trials (patients with age ⬎60 years and age close to 60 years). When combined, the weighted pooled mean increase in erect SBP and DBP was 5.58 mm Hg (pooled estimates of 95% CIs were 4.31–6.85) and 3.5 mm Hg (CIs 2.62– 4.38) respectively, due to increased NaCl consumption (low to high NaCl diet) (Tables 5A and 5B, respectively). The standardised weighted mean increase in SBP was 1.10 times more when com- Meta-analysis of NaCl and BP in the elderly S Alam and AG Johnson Table 4A 371 Pooled mean SBP with low and high salt diet Study details Weir et al, 1995 Lancet, 1989 Clin Exp Hyp, 1989 Silman et al, 1978 Age (years) 59.5 ± 3* 58.4 ± 1* 58.6 ± 1.1* 50–64 (ranged) Low Na SBP (erect) (mm Hg) 157 ± 3* 149.1 ± 1.9* 152 ± 2.2* 138.6 ± 8.4* High Na SBP (erect) (mm Hg) 162 ± 5* 152.2 ± 1.9* 155.6 ± 2.3* 139 ± 6.2* Weighted pooled mean change (mm Hg) s.d. difference Variance difference (Vd) 5 3.1 3.6 0.5 26.65 13.64 21.12 25.04 7.43 2.69 3.18 10.22 * Mean ± s.e.m. (standard error of the mean). Pooled mean treatment effect: 3.27 mm Hg. Associated standard error: 1.04. Pooled estimates of 95% confidence intervals: 1.23–5.31. Table 4B Pooled mean DBP with low and high salt diet Study details Weir et al, 1995 Lancet, 1989 Clin Exp Hyp, 1989 Silman et al, 1978 Age (years) Low Na DBP (erect) (mm Hg) High Na DBP (erect) (mm Hg) Weighted pooled mean change (mm Hg) s.d. difference Variance difference (Vd) 59.5 ± 3 58.4 ± 1 58.6 ± 1.1 50–64 (ranged) 95.5 ± 2.5* 91.4 ± 0.7* 95 ± 0.7* 80.9 ± 3.6* 96.5 ± 2.5* 94.6 ± 0.9* 97.1 ± 0.6* 86.5 ± 2.7* 1 3.2 2.1 5.6 11.73 5.75 6.12 10.83 3.54 1.13 0.92 4.42 * Mean ± s.e.m. (standard error of the mean). Pooled mean treatment effect: 2.69 mm Hg. Associated standard error: 0.64. Pooled estimates of 95% confidence intervals: 1.44 –3.94. pared with DBP, which suggests that the effect of salt on SBP is greater than on DBP. In 11 trials, the erect mean differences in SBP were plotted against the dietary NaCl intakes (⌬, difference from low to high NaCl diets) achieved after high Na diet (1978–1997) (Figure 1). The regression analysis revealed a significant (P = 0.05) association between the level of SBP and the level of NaCl intake with Na intake accounting for 37% of the variability in SBP participants of these trials. In 11 trials, the erect mean differences in DBP were plotted against the dietary change in NaCl intake (⌬, difference from low to high NaCl diets) achieved after high Na diet (1978–1997) (Figure 2). The regression analysis showed that there was nonsignificant (P = 0.76) association between the level of DBP and the level of NaCl intake. Discussion Two hundred and eighteen (218) of the 251 trials initially found from different databases were excluded because those trials studied either middleaged or younger groups with extensive differences in age range. Of the remaining 33 trials, 21 matched the study criteria but had to be excluded because of inadequate or insufficient information or data required for this meta-analysis. Finally, from the remaining 12 trials, 11 were selected for the metaanalysis. One of two trials was included because both provided similar data in two different journals in different years. In the selected 11 trials, one of the trials did not provide an age but age range (50– 64 years). This was included because all the subjects were between 50 and 60 years and it was assumed that the mean age may be close to 60. Another trial was also included despite no given age or age range because the trial mentioned that all the study subjects were above 50 years and it was assumed that their age might be close to 60 years. Selection bias was minimised by independent evaluation of methods and results by two authors (SA & AJ). When trials were pooled separately, ie, subjects age ⭓60 years and mean age below but close to 60 years (which included most of the subjects close to 60 and also some middle-aged subjects) it was found that chronic high NaCl intake increased both SBP and DBP but the increment for SBP was much greater than for DBP. When compared between groups, chronic high NaCl intake caused a greater increase in SBP in the former group (5.46 vs 3.27 mm Hg) but not for DBP (2.69 vs 2.63 mm Hg). The above data suggested that SBP increased more than DBP in both age groups studied but increases in SBP in subjects whose age was ⬎60 years were more when compared with increases in SBP in subjects whose mean age was below but close to 60 years. Results suggested a positive association with SBP, high NaCl intake and aging. Consequently, dietary restriction of NaCl might be useful in minimising the elevation of SBP in older individuals. When all trials were pooled, the meta-analysis demonstrated that switching diets from low to high NaCl increased SBP by 5.58 mm Hg and DBP by 3.5 Meta-analysis of NaCl and BP in the elderly S Alam and AG Johnson 372 Table 5A Pooled mean SBP with low and high salt diet (1978–1997) Study details Nestel et al, 1993 Palmer et al, 1989 Fotherby et al, 1997 Schorr et al, 1996 Cappuccio et al, 1997 Weir et al, 1995 Lancet, 1989 Kurtz et al, 1987 Clin Exp Hyp, 1989 Silman et al, 1978 Morgan et al, 1978 Age (years) 60–79 78–96 66–79 60–72 60–78 59.5 ± 3 58.4 ± 1 58.4 58.6 ± 1.1 50–64 (ranged) ⬎50 Low Na SBP (erect) (mm Hg) 122.91 ± 9.55 144.14 ± 8.77 168 ± 25 125.71 ± 15.71 151.1 ± 21.2 157 ± 3 149.1 ± 1.9 126 ± 4 152 ± 2.2 138.6 ± 8.4 152.4 ± 2.5 High Na SBP (erect) (mm Hg) 127.73 ± 13.18 154.43 ± 10.22 174 ± 22 132.86 ± 22.86 155 ± 21.5 162 ± 5 152.2 ± 1.9 142 ± 4 155.6 ± 2.3 139 ± 6.2 160 ± 4 Weighted pooled mean change (mm Hg) s.d. difference Variance difference (Vd) 4.82 10.29 6 7.15 3.9 5 3.1 16 3.6 0.5 7.6 11.51 23.32 23.55 19.61 21.35 26.65 13.64 8.94 21.12 25.04 18.57 2 13.46 8.08 6.93 4.4 7.43 2.69 5.65 3.18 10.22 4.72 Weighted pooled mean change (mm Hg) s.d. difference Variance difference (Vd) 2.28 5.43 3 2.86 2.1 1 3.2 8 2.1 5.6 9.3 8.22 13.13 12.51 10.42 9.64 11.73 5.75 7.07 6.12 10.83 8.81 1.43 7.58 4.29 3.86 1.99 3.54 1.13 4.47 0.92 4.42 2.24 Pooled mean treatment effect: 5.58 mm Hg. Associated standard error: 0.65. Pooled estimates of 95% confidence intervals: 4.31–6.85. Table 5B Pooled mean DBP with low and high salt diet (1978–1997) Study details Nestel et al, 1993 Palmer et al, 1989 Fotherby et al, 1997 Schorr et al, 1996 Cappuccio et al, 1997 Weir et al, 1995 Lancet, 1989 Kurtz et al, 1987 Clin Exp Hyp, 1989 Silman et al, 1978 Morgan et al, 1978 Age (years) 60–79 78–96 66–79 60–72 60–78 59.5 ± 3 58.4 ± 1 58.4 58.6 ± 1.1 50–64 (ranged) ⬎50 Low Na DBP (erect) (mm Hg) 72.45 70.86 99 70 91.6 95.5 91.4 76 95 80.9 100.3 ± ± ± ± ± ± ± ± ± ± ± 7.36 4.85 12 9.29 8.7 2.5 0.7 2 0.7 3.6 1 High Na DBP (erect) (mm Hg) 74.73 76.29 102 72.86 93.7 96.5 94.6 84 97.1 86.5 109.6 ± ± ± ± ± ± ± ± ± ± ± 9 5.83 13 11.43 10.5 2.5 0.9 4 0.6 2.7 2 Pooled mean treatment effect: 3.5 mm Hg. Associated standard error: 0.45. Pooled estimates of 95% confidence intervals: 2.62– 4.38. Figure 1 Erect mean change in SBP are plotted against the dietary sodium intakes (⌬, difference from low to high salt diet) achieved after high salt diet, in 11 trials (1978–1997). The regression analysis showed that there was a positive association between the level of SBP and the level of salt intake (P = 0.05, R = 0.06). The results also suggested that approximately 37% of variation an increase in SBP was attributed to the change in salt intake (r2 = 0.37). Figure 2 Erect mean change in DBP are plotted against the dietary change in sodium intakes (⌬, difference from low to high salt diet) achieved after high salt diet, in 11 trials (1978–1997). The regression analysis showed that there was nonsignificant association between the level of DBP and the level of salt intake (P = 0.76, r2 = 0.01 and R = 0.10). Meta-analysis of NaCl and BP in the elderly S Alam and AG Johnson mm Hg. This suggests that in older individuals increasing NaCl intake produce a significant elevation in BP, which is greater for SBP than for DBP. When the increase in erect SBP data from all trials were pooled with the dietary changes in NaCl intake, linear regression analysis revealed a significant association between SBP but not DBP, and the level of NaCl intake. This indicated that the level of SBP in the elderly was positively and strongly influenced by the level of NaCl consumption. A reduction of 100 mmol Na excretion in hypertensive subjects from 25–55 years caused an average 9 mm Hg drop in SBP and represents a positive and statistically significant (P ⬍ 0.001) association between the slope of BP and age with Na excretion. The association of NaCl intake and SBP for the older age group compared with other age groups was greater and more significant.27 In essential hypertensive subjects (25–80 years) high NaCl intake significantly elevated BP (P ⬍ 0.001) and pronounced saltsensitivity (SS, 91%) more in the older age group only, suggesting that age predicts the BP changes resulting from high NaCl intake and SS associated with the age-related changes in renal and endocrine function.28 Excessive NaCl intake may contribute to the pathogenesis of hypertension, particularly SS hypertension.29 How clinically important is reduction in SBP of 5.58 mm Hg and DBP of 3.5 mm Hg by reduced dietary NaCl intake? Law et al30 demonstrated that for subjects with normal and high BP, a 50 mmol/day reduction in NaCl intake for a few weeks can reduce SBP by 5 and 7 mm Hg respectively, DBP by 2.5 and 3.5 mm Hg respectively and lower the occurrence of ischaemic heart disease (IHD) by 15% and stroke by 26%. In an entire western population, such a NaCl reduction would reduce BP by 5 mm Hg and prevent mortality from IHD and stroke by 16% and 22% respectively. By combining restricted NaCl of 50 mmol and 100 mmol/day with BP medication, mortality from IHD and stroke would reduce by 20% and 30% respectively.30,31 In the elderly population, the occurrence of hypertension, particularly ISH, is rapidly increasing and is an important determinant of cardiovascular risk.32 Mechanisms possibly responsible for developing BP in elderly subjects include reduced arterial compliance, elevated peripheral vascular resistance, alteration in cardiac output, reduction in plasma renin activity and decreased beta-adrenergic function. Additionally, environmental factors such as diet, SS status and genetic predisposition may also contribute to hypertension.33 Observational studies within western populations revealed a strong and positive association (P ⬍ 0.001) between NaCl intake and BP.30,31 Our meta-analysis in the elderly demonstrated that increased salt ingestion caused a significant increase in SBP, suggesting a possible pathogenetic role for salt in the initiation and/or maintenance of ISH. In conclusion, a chronic high salt dose in elderly individuals with essential hypertension significantly elevated SBP and DBP, but the effect was more marked for SBP when compared with DBP and the older the patient. Therefore, chronic high salt dose is an important determinant of SBP in elderly hypertensive patients. References 1 Lichtenstein MJ. Isolated systolic hypertension: how common? How risky? South Med J 1985; 78: 972–978. 2 Nielsen WB, Svendsen TL, Rasmussen SP. Isolated systolic hypertension in the elderly. Ugeskr Laeger 1994; 156: 1455–1459. 3 Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens 1995; 9: 175–180. 4 Luft FC et al. Effects of ageon renal sodium homeostasis and its relevance to sodium Sensitivity. Am J Med 1987; 82 (Suppl 1B): 9–15. 5 Grzegarczyk PB, Jones CW, Mistretta CM. Age related differences in salt taste acuity. J Gerontol 1979; 324: 834 –860. 6 Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications (clinical conference). Hypertension 1994; 23: 531–550. 7 Ogihara T et al. Guidelines on treatment of hypertension in the elderly 1995—a tentative plan for guidelines on treatment of hypertension in the elderly, comprehensive research projects on aging and health, the Ministry of Health and Welfare of Japan. Nippon Ronen Igakkai Zasshi 1996; 33: 945–975. 8 Chalmers TC et al. A method for assessing the quality of a randomized control trial. Controlled Clin Trials 1981; 2: 31– 49. 9 Fotherby MD, Potter JF. Metabolic and orthostatic blood pressure responses to a low sodium diet in elderly hypertensives. J Hum Hypertens 1997; 11: 361– 366. 10 Fotherby MD, Potter JF. Effects of moderate sodium restriction of clinic and twenty-four-hour ambulatory blood pressure in elderly hypertensive subjects. J Hypertens 1993; 11: 657–663. 11 Nestel PJ et al. Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio. J Hypertension 1993; 11: 1387– 1394. 12 Palmer RM, Osterweil D, Lustig GL, Stern N. The effect of dietary salt ingestion on blood pressure of old-old subjects. A double-blind, placebo-controlled, crossover trial. J Am Geriatr Soc 1989; 37: 931–936. 13 Schorr U, Distler A, Sharma AM. Effect of sodium chloride and sodium bicarbonate rich mineral water on blood pressure and metabolic parameters in elderly normotensive individuals: A randomized double-blind crossover trial. J Hypertens 1996; 14: 131–135. 14 Cappuccio FP et al. Double-blind randomised trial of modest salt restriction in older people. Lancet 1997; 350 (908): 850–854. 15 Weir MR, Dengel DR, Behrens MT, Goldberg AP. Saltinduced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995; 25: 1339–1344. 16 Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Lancet 1989; 1 (8635): 399– 402. 17 Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Effects of replacing sodium intake in subjects on a low sodium diet: a crossover study. Clin and Exp Hypertens A 1989; 11: 1011–1024. 373 Meta-analysis of NaCl and BP in the elderly S Alam and AG Johnson 374 18 Silman AJ, Mitchell P, Locke C, Humpherson P. Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension. Lancet 1983; 1 (8335): 1179–1182. 19 Kurtz TW, Al-Bander HA, Morris RC. Salt-sensitive essential hypertension in men. Is the sodium ion alone important? N Engl J Med 1987; 317: 1043–1048. 20 Morgan T et al. Hypertension treated by salt restriction. Lancet 1978; 1 (8058): 227–230. 21 Gardner MJ, Altman DG. Confidence intervals rather than p values: Estimation rather than hypothesis testing. Br Med J Clin Res Ed 1986; 292 (6522): 746–750. 22 Kirkwood BR. Comparison of two means. In: Essential of Medical Statistics. Blackwell Scientific Publications: London, 1988, pp 41– 45. 23 Kirkwood BR. Confidence interval for a mean. In: Essential of Medical Statistics. Blackwell Scientific Publications: London, 1988, pp 27–32. 24 Cappuccio FP, MacGregor GA. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens 1991; 9: 465–73. 25 Rosenthal R, Rubin DB. Comparing effect sizes of independent studies. Psychol Bull 1982; 92: 500–504. 26 Kirkwood BR. Measures of mortality and morbidity. In: Essential of Medical Statistics. Blackwell Scientific Publications: London, 1988, pp 106–117. 27 Elliott P. Observational studies on salt and blood pressure. Hypertension 1991; 7: 13–18. 28 Overlack A et al. Age is a major determinant of the divergent blood pressure responses to varing salt intake in essential hypertension. Am J Hypertens 1995; 8: 829–836. 29 Carrageta MO, Negrao L, de-Padua F. Community based stroke prevention: a Portuguese challenge. Health Res 1994; 6: 189–195. 30 Law MR, Frost CD, Wald NJ. 111 Analysis of observational data within populations. BMJ 1991; 302: 815–818. 31 Law MR, Frost CD, Wald NJ. 111 Analysis of observational data within populations. BMJ 1991; 302: 819–824. 32 Sowers JR. Hypertension in the elderly. Am J Med 1987; 82 (Suppl 1B): 1–8. 33 Furmaga EM, Murphy CM, Carter BL. Isolated systolic hypertension in older patients. Clin Pharm 1993; 12: 347–358.